Effects of hand hygiene product on the incidence of infection disease

Not Applicable

• Conditions: none

• Registration Number: JPRN-jRCTs031210205
• Lead Sponsor: Hori Satoshi

Brief Summary

o adverse event causing use of the test product occurred. There were no significant differences on any of the efficacy endpoints. Since the number of infections in the Active group was half of that in the Placebo group, it was inferred that using the hand hygiene products might be effective for preventing infectious disease. This study needs to be validated again, at the appropriate time when the primary and secondary endpoints occur sufficiently.

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-07-21
• Study Completion: 2022-02-28
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 662

Inclusion Criteria

1, Healthy men and women between 20 and 65 years old
2, Subjects who have written consent to participate in this study
3, Subjects who can implement standard infection from the informed consent.

Exclusion Criteria

1, Subjects who have received medications or undergone surgery due to a cold, illness or injury requiring hospitalization within 2 months before this study. excluding medication for transient symptoms such as hay fever, stomach ache and headaches
2, Subjects with upper respiratory tract infections such as common cold or influenza infection when getting consent in this study.
3, Subjects with rough or itchy hands due to eczema or dermatitis
4, Subjects with allergy symptoms caused by drugs
5, Subjects who are or may be pregnant
6, Subjects who do not have a device that can do wnload and use the physical condition management application.
7, Subjects who do not agree to bear the communication costs associated with downloading and inputting the physical condition management application.
8, Healthcare workers involved in the examination and treatment of patients.
9, Subjects deemed unsuitable for inclusion in this study by the principal investigator.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cumulative incidence rate of AURI-like symptoms

Secondary Outcome Measures

Name	Time	Method
Cumulative incidence rate of ILI, Cumulative incidence rate of Flu and Cumulative incidence rate of COVID-19